Eva M Pastor-Arroyo

Eva M Pastor-Arroyo

UNVERIFIED PROFILE

Are you Eva M Pastor-Arroyo?   Register this Author

Register author
Eva M Pastor-Arroyo

Eva M Pastor-Arroyo

Publications by authors named "Eva M Pastor-Arroyo"

Are you Eva M Pastor-Arroyo?   Register this Author

8Publications

274Reads

16Profile Views

The Transmodulation of HER2 and EGFR by Substance P in Breast Cancer Cells Requires c-Src and Metalloproteinase Activation.

PLoS One 2015 26;10(6):e0129661. Epub 2015 Jun 26.

Department of Medical Oncology, Hospital Clínic, Barcelona, Spain; Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain; Department of Medicine, University of Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0129661PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4482606PMC
April 2016

Comparison of methods for the isolation of human breast epithelial and myoepithelial cells.

Front Cell Dev Biol 2015 21;3:32. Epub 2015 May 21.

Department of Medical Oncology, Hospital Clínic Barcelona, Spain ; Department of Medicine, University of Barcelona Barcelona, Spain ; Institut d'Investigacions Biomediques August Pi i Sunyer Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fcell.2015.00032DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4440402PMC
June 2015

Substance P autocrine signaling contributes to persistent HER2 activation that drives malignant progression and drug resistance in breast cancer.

Cancer Res 2013 Nov 12;73(21):6424-34. Epub 2013 Sep 12.

Authors' Affiliations: Department of Medical Oncology and Pathology, Hospital Clínic, Institut d'Investigacions Biomediques August Pi i Sunyer, Department of Medicine, University of Barcelona; Department of Cell Biology, Immunology, and Neurosciences, Medical School, University of Barcelona, Barcelona, Spain; Department of Pathology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea; Department of Genetics, Oslo University Hospital Radiumhospitalet, Norway; and Department of Medicine and Experimental Oncology, Torino University, Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-12-4573DOI Listing
November 2013